Search for:

Webmail
UCD Access
Canvas
Quick Links

Department of Medicine

School of Medicine

Home
About Us

Affiliated Hospitals

Contact Us

Giving

History

Leadership

DOM Administrative Toolbox
Newsroom
Divisions
Quality and Patient Safety

About Us

Leaders in Informatics, Quality & Systems Fellowship

Quality Council

Patient Care

Find a Doctor
Education

Medicine-Pediatrics Residency Program

Internal Medicine Residency Program

Fellowships

Program for Academic Clinician Educators (PACE)

Grand Rounds
Research
Faculty and Staff

Clinical Excellence Society

Faculty Development

Faculty Promotion and Tenure

Faculty and Staff Recognition

Equity

Mentorship

WellDOM

Faculty Performance Reviews
Events

Annual Shark Tank Competition

Division Conferences

Mentorship Academy

Research and Innovation Conference

Research Day

State of the Department

Systems Improvement & Collaborative Case Review

Early Signals of Efficacy With Cystic Fibrosis Gene Therapy

Default sub title

minute read

by CGTLive | August 26, 2024

4D Molecular Therapeutics’ 4D-710 is an investigational gene therapy currently being evaluated for the treatment of cystic fibrosis (CF) in the phase 1/2 AEROW clinical trial (NCT05248230).

Topics: Press Coverage

Spread the word:

Related Articles

Department of Medicine (SOM)

CU Anschutz

Academic Office One

12631 East 17th Avenue

8601

Aurora, CO 80045

303-724-1785

Facebook Twitter

Department of Medicine

Residency and Fellowship Programs

School

School of Medicine

Directories

Find a Researcher

Find a Faculty Member

Affiliate/Partner Hospitals

Maps and Parking

Give

Contact Us
Website Feedback
CU System
Privacy Policy
Terms of Use
Accessibility
Accreditation
Employment
Give Now

© 2024 The Regents of the University of Colorado, a body corporate. All rights reserved.

Accredited by the Higher Learning Commission. All trademarks are registered property of the University. Used by permission only.